Table 2.
Control (n = 39) | ARM (n = 64) | CNV (n = 51) | |
---|---|---|---|
Age range (years) | 60–90 | 50–88 | 65–95 |
Mean age (years) | 75·39 | 74·56 | 82·2 |
The above data show the demographic distribution of age and gender in all groups. The age range is younger in the age-related maculopathy (ARM) group in comparison to the choroidal neovascularization (CNV) group; this reflects the end stage of the disease process in older patients.